| |
|
|
|
|
|
For the direct quantitative determination of 3 Diol G by
enzyme immunoassay in human serum.
For in vitro diagnostic use only.`
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
For the direct quantitative determination of 3α Diol G by
enzyme immunoassay in human serum.
For non-clinical research use only.
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Radioimmunoassay for the in vitro quantitative measurement of human 5α-Androstane-3α-17β-Diol-Glucuronide (3α-
Diol G) in serum and plasma.
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Androstanediol Glucuronide Test
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Androstanediol Glucuronide Test
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Hyperandrogenism, clinically expressed by hirsutism and virilization, is generated by an
excess in androgen production in typical circumstances, such as steroid secreting neoplasms
of the adrenals and the ovaries, adult-onset congenital adrenal hyperplasia, hyperthecosis
and polycystic ovarian syndrome (PCOS).
|
Company:
Date:
December 01, 2008
|
|
|
|
|
|
|
|
|
|
Androstanediol Glucuronide (ADG) RIA
|
Company:
Date:
March 03, 2009
|
|
|
|
|